Literature DB >> 1280374

Current management of hilar cholangiocarcinoma.

S C Stain1, H U Baer, A R Dennison, L H Blumgart.   

Abstract

The goal in the treatment of hilar cholangiocarcinoma is the relief of biliary obstruction with the quality survival. The choice of therapy for an individual patient requires complete preoperative staging to determine the resectability. This is best accomplished in a multidisciplinary setting with radiologists, gastroenterologists and surgeons participating in the diagnostic and therapeutic strategies. Operative removal of the tumor can be performed with low mortality and, when possible, provides the longest palliation and offers potential for cure. For tumors found at operation to be unresectable, biliary enteric bypass provides a durable method of palliation. The relative merits of the newer methods of radiologic stenting are encouraging, but further study will require prospective trials in comparison to operative biliary enteric bypass.

Entities:  

Mesh:

Year:  1992        PMID: 1280374

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  10 in total

1.  Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.

Authors:  S A Khan; B R Davidson; R Goldin; S P Pereira; W M C Rosenberg; S D Taylor-Robinson; A V Thillainayagam; H C Thomas; M R Thursz; H Wasan
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

2.  Cholangiocarcinoma.

Authors:  Prabhleen Chahal; Todd H Baron
Journal:  Curr Treat Options Gastroenterol       Date:  2005-12

Review 3.  Cholangiocarcinoma and its management.

Authors:  S A Khan; A Miras; M Pelling; S D Taylor-Robinson
Journal:  Gut       Date:  2007-12       Impact factor: 23.059

4.  Palliative decompression of obstructive hilar malignancies utilizing an extrahilar biliary approach.

Authors:  S Yilmaz; V Kirimlioglu; D A Katz; M Caglikulekci; M Yilmaz
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

5.  Air cholangiogram is not inferior to dye cholangiogram for malignant hilar biliary obstruction: a randomized study of efficacy and safety.

Authors:  Randhir Sud; Rajesh Puri; Narendra S Choudhary; Ashish Mehta; Parvesh Kumar Jain
Journal:  Indian J Gastroenterol       Date:  2015-01-24

6.  Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies.

Authors:  Yoshifumi Kawarada; Bidhan C Das; Tatsushi Naganuma; Masami Tabata; Hiroki Taoka
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

7.  Primary patency of percutaneously inserted self-expanding metallic stents in patients with malignant biliary obstruction.

Authors:  Ursula Dahlstrand; Gabriel Sandblom; Lars-Gunnar Eriksson; Rickard Nyman; Ib Christian Rasmussen
Journal:  HPB (Oxford)       Date:  2009-06       Impact factor: 3.647

8.  Preoperative assessment of hilar cholangiocarcinoma using multidetector-row CT: correlation with histopathological findings.

Authors:  Takeyuki Watadani; Masaaki Akahane; Takeharu Yoshikawa; Kuni Ohtomo
Journal:  Radiat Med       Date:  2008-09-04

9.  The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo.

Authors:  Olga Atochina; Akram A Da'dara; Mirjam Walker; Donald A Harn
Journal:  Immunology       Date:  2008-03-28       Impact factor: 7.397

10.  MR imaging of intrahepatic cholangiocarcinoma.

Authors:  P Soyer; D A Bluemke; A Sibert; J P Laissy
Journal:  Abdom Imaging       Date:  1995 Mar-Apr
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.